{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:31:44Z","timestamp":1789950704346,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T00:00:00Z","timestamp":1369267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12664-013-0334-1","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T04:54:53Z","timestamp":1369198493000},"page":"307-310","source":"Crossref","is-referenced-by-count":13,"title":["Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B"],"prefix":"10.1007","volume":"32","author":[{"given":"Mukund Ramchandra","family":"Mogarekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati Jitendra","family":"Talekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,23]]},"reference":[{"key":"334_CR1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1096\/fj.00-0650rev","volume":"15","author":"H Tsukamoto","year":"2001","unstructured":"Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 2001;15:1335\u201349.","journal-title":"FASEB J"},{"key":"334_CR2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1006\/geno.1996.0225","volume":"33","author":"SL Primo-Parmo","year":"1996","unstructured":"Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family. Genomics. 1996;33:498\u2013507.","journal-title":"Genomics"},{"key":"334_CR3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","volume":"101","author":"M Aviram","year":"1998","unstructured":"Aviram M, Rosenblat M, Bisgauier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581\u201390.","journal-title":"J Clin Invest"},{"key":"334_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/clinchem\/48.2.261","volume":"48","author":"N Ferre","year":"2002","unstructured":"Ferre N, Camps J, Prats E, et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem. 2002;48:261\u20138.","journal-title":"Clin Chem"},{"key":"334_CR5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1742-1241.2006.01206..x","volume":"62","author":"M Aslan","year":"2008","unstructured":"Aslan M, Horoz M, Nazligul Y, et al. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis. Int J Clin Pract. 2008;62:1050\u20135.","journal-title":"Int J Clin Pract"},{"key":"334_CR6","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.3748\/wjg.v11.i46.7351","volume":"11","author":"SS Killic","year":"2005","unstructured":"Killic SS, Aydin S, Killic N, Erman F, Aydin S, Celik I. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. World J Gastroenterol. 2005;11:7351\u20134.","journal-title":"World J Gastroenterol"},{"key":"334_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4020-6561-3_12","volume-title":"Paraoxonase-1 in chronic liver diseases, neurological diseases, and HIV infection. The paraoxonases: their role in disease development and xenobiotic metabolism","author":"J Marsillach","year":"2008","unstructured":"Marsillach J, Parra S, Ferr\u00e9 N, et al. Paraoxonase-1 in chronic liver diseases, neurological diseases, and HIV infection. The paraoxonases: their role in disease development and xenobiotic metabolism. Dordrecht: Springer; 2008. p. 187\u201398."},{"key":"334_CR8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","volume":"28","author":"S Billecke","year":"2000","unstructured":"Billecke S, Draganov D, Counsell R, et al. Human serum paraoxonase (PON1) isozymes Q And R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos. 2000;28:1335\u201342.","journal-title":"Drug Metab Dispos"},{"key":"334_CR9","first-page":"1126","volume":"35","author":"HW Eckerson","year":"1983","unstructured":"Eckerson HW, Wyte CM, LA Du BN. The human serum paraoxonase\/arylesterase polymorphism. Am J Hum Genet. 1983;35:1126\u201338.","journal-title":"Am J Hum Genet"},{"key":"334_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinbiochem.2008.09.120","volume":"42","author":"J Marsillach","year":"2009","unstructured":"Marsillach J, Aragones G, Beltran R, et al. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem. 2009;42:91\u20138.","journal-title":"Clin Biochem"},{"key":"334_CR11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0009-9120(99)00056-9","volume":"32","author":"DB Hill","year":"1999","unstructured":"Hill DB, Devarajan R, Joshi-Barve S, Barve S, McClain CJ. Antioxidants attenuate nuclear factor-Kappa B activation and tumor necrosis factor-alpha production in alcohol hepatitis patient monocytes and rat Kupffer cells, in vitro. Clin Biochem. 1999;32:563\u201370.","journal-title":"Clin Biochem"},{"key":"334_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/1319-3767.61232","volume":"16","author":"V Kedage","year":"2010","unstructured":"Kedage V, Muttigi MS, Shetty MS, et al. Serum paraoxonase activity status in patients with liver disorders. Saudi J Gastroenterol. 2010;16:79\u201383.","journal-title":"Saudi J Gastroenterol"},{"key":"334_CR13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0022-2275(20)33445-3","volume":"41","author":"T Kujiraoka","year":"2000","unstructured":"Kujiraoka T, Oka T, Ishihara M, et al. A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration. J Lipid Res. 2000;41:1358\u201363.","journal-title":"J Lipid Res."},{"key":"334_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4020-6561-3_1","volume-title":"Paraoxonases: an historical perspective. The paraoxonases: their role in disease development and xenobiotic metabolism","author":"CE Furlong","year":"2008","unstructured":"Furlong CE. Paraoxonases: an historical perspective. The paraoxonases: their role in disease development and xenobiotic metabolism. Dordrecht: Springer; 2008. p. 3\u201331."},{"key":"334_CR15","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/bi047440d","volume":"44","author":"O Khersonsky","year":"2005","unstructured":"Khersonsky O, Tawfik DS. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry. 2005;44:6371\u201382.","journal-title":"Biochemistry"},{"key":"334_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jbt.20181","volume":"21","author":"CE Furlong","year":"2007","unstructured":"Furlong CE. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. J Biochem Mol Toxicol. 2007;21:197\u2013205.","journal-title":"J Biochem Mol Toxicol"},{"key":"334_CR17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.clinbiochem.2007.01.020","volume":"40","author":"J Marsillach","year":"2007","unstructured":"Marsillach J, Ferre N, Vila MC, et al. Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease. Clin Biochem. 2007;40:645\u201350.","journal-title":"Clin Biochem"},{"key":"334_CR18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","volume":"26","author":"M Aviram","year":"1999","unstructured":"Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med. 1999;26:892\u2013904.","journal-title":"Free Radic Biol Med"},{"key":"334_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2005.12.018","volume":"45","author":"N Ferr\u00e9","year":"2006","unstructured":"Ferr\u00e9 N, Marsillach J, Camps J, et al. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J Hepatol. 2006;45:51\u20139.","journal-title":"J Hepatol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-013-0334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-013-0334-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-013-0334-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:54:07Z","timestamp":1746010447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-013-0334-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,23]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s12664-013-0334-1","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,23]]}}}